INS and metabolic dysfunction-associated steatotic liver disease: Further, more clarity is needed to define the structural changes in the IR in an insulin-resistant state and to determine if activation of the insulin receptor is necessary for lipogenesis in NAFLD after the onset of fatty liver disease.